ArticleTobacco induced diseases2025
Assessing the impact of tobacco smoke exposure on earlyonset osteoarthritis: A cross-sectional analysis of secondary data from the National Health and Nutrition Examination Survey (NHANES), 1999-2020.
Article in Tobacco induced diseases, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionThere is evidence that exposure to tobacco smoke is associated to a number of chronic diseases, but the evidence for an association with osteoarthritis (OA) is sparse and inconclusive. The aim of this study was to investigate whether exposure to tobacco smoke for an adult is associated with developing OA at a young age, and to assess dose-response patterns.
methodsWe conducted a pooled, cross-sectional analysis of secondary data from the National Health and Nutrition Examination Survey (NHANES) 1999-2020 among US adults aged 20-54 years (n=26145). Tobacco smoke exposure was quantified by serum cotinine. Multivariable logistic regression, restricted cubic splines, and threshold analyses were used to estimate the dose-response relationship between cotinine and self-reported physician-diagnosed early-onset OA.
resultsOverall, 1086 participants (4.2%) reported early-onset OA. After full adjusted odds ratio (AOR), serum cotinine ≥3 ng/mL was associated with a 52% increase in odds of early-onset OA (AOR=1.52; 95% CI: 1.30-1.79), compared with <0.05 ng/mL. A non-linear, positively saturated relationship was observed between the cotinine levels after the natural logarithm (LN) transformation and early-onset OA, with an inflection point at approximately 2.90 ng/mL (AOR=1.38; 95 % CI: 1.17-1.63, p=0.00). Subgroup analyses confirmed the robustness of this association across demographic and clinical strata.
conclusionsThis study, based on a nationally representative sample from the United States, suggests that high levels of tobacco smoke exposure significantly increase the likelihood of early-onset OA, highlighting the need for further research into factors associated with early-onset OA.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.